Search - tctmd.com

Displaying 1 - 20 of 86

Sort: Relevancy | Date

STEMI Patients With Multivessel Disease Best Served by a Single Procedure: Meta-analysis

News Daily News

STEMI Patients With Multivessel Disease Best Served by a Single, Complete Procedure: Meta-analysis

Caitlin E. Cox

December 15, 2017

News Daily News

USPSTF Upholds Stance Against Hormone Therapy to Prevent Chronic Diseases in Menopausal Women

Caitlin E. Cox

December 12, 2017

News Daily News

Dreams Dashed: Intravascular Therapy for MS Flops in Sham-Controlled Trial

L.A. McKeown

December 05, 2017

News Daily News

It’s Official: Evolocumab Gains Claim for CVD Event Reduction

Michael O'Riordan

December 04, 2017

News Conference News AHA 2017

RE-DUAL PCI Findings Consistent Across Key Subgroups

Todd Neale

November 16, 2017

News Conference News AHA 2017

Sustained Blood Pressure Reductions With Gastric Bypass Surgery: GATEWAY

Michael O'Riordan

November 16, 2017

News Conference News AHA 2017

Continuing NOACs During Device Surgery Does Not Reduce Pocket Hematoma

Todd Neale

November 15, 2017

News Conference News AHA 2017

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

Michael O'Riordan

November 13, 2017

News Conference News AHA 2017

Big BP Reductions When DASH Diet Combined With Low Sodium Intake

Michael O'Riordan

November 12, 2017

News Conference News TCT 2017

Longer-term Outcomes of Watchman Reassure as Debate Continues Over How It Should Be Used

Todd Neale

November 02, 2017

News Opinion Editor's Corner TCT 2017

Live From Denver: TCT 2017, Day Four

Shelley Wood

November 02, 2017

News Opinion Off Script TCT 2017

Off Script: Connecting and Collaborating in the Global Village of Interventional Cardiology

Kwan S. Lee

November 01, 2017

News Conference News TCT 2017

Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery

Yael L. Maxwell

October 31, 2017

News Conference News TCT 2017

No Advantage With Hybrid Revascularization for Multivessel Disease: HREVS

Michael O'Riordan

October 30, 2017

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Shelley Wood

October 20, 2017

News Daily News

Women, Minorities at Greater Risk for Non-Stent-Related Events After PCI

Yael L. Maxwell

October 20, 2017

News Daily News

NOAC Bleeding Risk Rises With Several Drug Combinations

Michael O'Riordan

October 06, 2017

News Conference News PCR London Valves 2017

Pacemakers and Paravalvular Leak With Lotus: Updates From REPRISE III

Shelley Wood

September 27, 2017

News Conference News PCR London Valves 2017

As Percutaneous Mitral Valve Techniques Advance, Questions Turn to Combinations, Staging

Shelley Wood

September 26, 2017

News Industry News

Boston Scientific Announces U.S. FDA Approval for MRI Labeling on High-Voltage Devices and U.S. Launch of Resonate™ Devices with the HeartLogic™ Heart Failure Diagnostic

September 25, 2017

Advertisement

STEMI Patients With Multivessel Disease Best Served by a Single, Complete Procedure: Meta-analysis

USPSTF Upholds Stance Against Hormone Therapy to Prevent Chronic Diseases in Menopausal Women

Dreams Dashed: Intravascular Therapy for MS Flops in Sham-Controlled Trial

It’s Official: Evolocumab Gains Claim for CVD Event Reduction

RE-DUAL PCI Findings Consistent Across Key Subgroups

Sustained Blood Pressure Reductions With Gastric Bypass Surgery: GATEWAY

Continuing NOACs During Device Surgery Does Not Reduce Pocket Hematoma

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

Big BP Reductions When DASH Diet Combined With Low Sodium Intake

Longer-term Outcomes of Watchman Reassure as Debate Continues Over How It Should Be Used

Live From Denver: TCT 2017, Day Four

Off Script: Connecting and Collaborating in the Global Village of Interventional Cardiology

Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery

No Advantage With Hybrid Revascularization for Multivessel Disease: HREVS

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Women, Minorities at Greater Risk for Non-Stent-Related Events After PCI

NOAC Bleeding Risk Rises With Several Drug Combinations

Pacemakers and Paravalvular Leak With Lotus: Updates From REPRISE III

As Percutaneous Mitral Valve Techniques Advance, Questions Turn to Combinations, Staging

Boston Scientific Announces U.S. FDA Approval for MRI Labeling on High-Voltage Devices and U.S. Launch of Resonate™ Devices with the HeartLogic™ Heart Failure Diagnostic

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content